Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиSoleno Therapeutics Мультипликаторы 2011-2024 | SLNO
Мультипликаторы по годам Soleno Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.7 | -0.1 | -6.3 | -3.6 | -2.7 | -1.0 | -1.1 | -0.8 | -0.1 | - | - | - |
P/S |
- | - | - | - | - | - | 9.0 | 32.6 | - | - | - | - |
EPS |
-2.9 | -5.8 | -0.4 | -0.9 | -0.6 | -1.7 | -5.1 | -1.7 | -10.4 | -6.9 | - | - |
EV (Enterprise Value) |
18.9 млн | -1.66 млн | 126 млн | 112 млн | 25.7 млн | 11 млн | 12.5 млн | 12.1 млн | 12.5 млн | 38.2 млн | 36.7 млн | - |
EBITDA per Share |
-2.67 | -5.56 | -0.377 | -0.622 | -0.561 | -0.899 | -4.35 | -6.39 | -20.2 | - | - | - |
EV/EBITDA |
0.1 | -3.6 | -4.2 | -1.1 | 0.2 | -0.8 | -0.6 | 1.2 | - | - | - | |
PEG |
-0.0 | -0.0 | -0.32 | 0.09 | -0.04 | -0.02 | -0.03 | -0.01 | 0.0 | - | - | - |
P/B |
1.7 | 0.1 | 3.4 | 7.4 | 1.2 | 0.6 | 3.8 | 3.9 | -0.2 | - | - | - |
P/CF |
-0.8 | -0.1 | -6.2 | -6.3 | -3.1 | -1.6 | -1.0 | -1.2 | -0.4 | - | - | - |
ROE % |
-232.58 | -173.72 | -54.10 | -205.89 | -43.85 | -59.04 | -351.22 | -493.47 | 134.28 | - | - | - |
ROA % |
-90.83 | -86.94 | -37.92 | -80.62 | -30.90 | -40.15 | -216.81 | -193.98 | -165.25 | - | - | - |
ROCE % |
-235.77 | -177.19 | -56.68 | -69.85 | -33.28 | -25.96 | -352.82 | -242.78 | -72.61 | - | - | - |
Current Ratio |
1.6 | 2.0 | 5.8 | 4.3 | 13.1 | 10.4 | 2.2 | 2.0 | 6.5 | - | - | - |
DSO |
- | - | - | - | - | - | 33.5 | 147.0 | - | - | - | - |
DIO |
- | - | - | - | - | - | 159.7 | 570.3 | - | - | - | - |
DPO |
- | - | - | - | - | - | 130.1 | 719.3 | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | 193.3 | 717.3 | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | 63.2 | -2.0 | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Soleno Therapeutics
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.81 | -0.88 | - | -0.76 | -0.72 | -1.07 | - | -1.53 | -0.14 | -0.11 | - | -0.11 | -0.16 | -0.13 | - | 0.03 | -0.31 | -0.22 | - | -0.13 | -0.35 | -0.19 | - | -1.71 | -0.42 | -0.57 | - | -0.87 | -0.23 | -220 | - | -0.33 | 0.25 | -1.67 | - | -10.42 | -5.21 | -10.42 | - | -2.97 | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | -0.84 | - | -0.59 | -0.62 | -0.99 | - | -1.28 | -0.13 | -0.11 | - | -0.08 | -0.22 | -0.2 | - | -0.15 | -0.15 | -0.14 | - | -0.11 | -0.12 | -0.15 | - | -0.17 | -0.25 | -0.25 | - | -0.62 | -0.14 | - | - | -0.31 | -0.4 | -0.35 | - | -2.43 | -2.41 | -1.26 | - | -1.79 | - | - | - | - | - | - | - | - | - | - |
ROE % |
-465.52 | -430.43 | -95.09 | -135.38 | -135.33 | -142.26 | -104.17 | -122.93 | -101.40 | -77.57 | -47.83 | -41.89 | -17.18 | -67.92 | -108.04 | -117.04 | -131.98 | -88.23 | -44.71 | -58.83 | -63.95 | -55.70 | -39.96 | -120.01 | -185.95 | -273.27 | -275.17 | -377.34 | -399.45 | -238.82 | -405.31 | -287.00 | -66.53 | -6.59 | 354.91 | 359.11 | 245.00 | 126.70 | 4.20 | 4.20 | - | - | - | - | - | - | - | - | - | - |
ROA % |
-108.51 | -99.37 | -50.87 | -70.00 | -69.95 | -74.23 | -57.44 | -70.59 | -64.62 | -53.45 | -33.53 | -31.20 | -15.72 | -30.58 | -42.31 | -48.65 | -57.32 | -47.45 | -31.51 | -41.21 | -44.58 | -38.39 | -27.27 | -76.69 | -116.40 | -169.36 | -169.85 | -210.00 | -200.74 | -114.68 | -159.29 | -316.96 | -434.47 | -615.08 | -473.01 | -573.20 | -515.72 | -358.05 | -100.19 | -100.19 | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-82.04 | -115.42 | -96.22 | -137.23 | -137.23 | -144.25 | -105.79 | -123.04 | -99.27 | -83.45 | -62.20 | -103.24 | -127.02 | -140.06 | -111.96 | -124.71 | -96.43 | -70.03 | -35.40 | -45.21 | -42.27 | -42.23 | -26.17 | -83.46 | -130.94 | -186.57 | -248.21 | -303.34 | -301.17 | -282.86 | -113.94 | -102.11 | -35.16 | -5.06 | -16.20 | -13.57 | -22.77 | -4.38 | 2.62 | 2.62 | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.7 | 1.2 | 1.6 | 1.9 | 2.2 | 2.6 | 2.0 | 1.9 | 2.3 | 3.0 | 3.3 | 3.3 | 3.3 | 3.3 | 1.6 | 1.6 | 1.6 | 1.6 | 3.4 | 3.4 | 3.4 | 3.4 | 3.2 | 3.2 | 3.1 | 3.1 | 2.6 | 2.6 | 2.6 | 2.6 | 1.6 | 1.0 | 0.5 | 0.4 | 0.4 | - | 0.4 | 0.4 | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5155.6 | 19.5 | - | 19.4 | 3102.5 | 29.5 | - | 57.6 | 146.8 | 323.5 | - | - | - | - | - | 2.3 | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1107.0 | 186.7 | - | 168.9 | 1282.9 | 119.8 | - | 897.8 | 2285.4 | 1673.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1375.3 | 227.8 | - | 94.0 | 849.0 | 122.0 | - | 1132.5 | 2882.7 | 4262.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6262.6 | 206.1 | - | 188.3 | 4385.4 | 149.4 | - | 955.5 | 2432.2 | 1997.3 | - | - | - | - | - | 2.3 | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4887.3 | -21.7 | - | 94.3 | 3536.4 | 27.3 | - | -177.0 | -450.5 | -2265.6 | - | - | - | - | - | 2.3 | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD